Larvol Delta - Regulus-Therapeutics-Completes-Dosing-in-Phase-1-Multiple-Ascending-Dose-Study-of-RGLS4326-in-Healthy-Volunteers-for-the-Treatment-of-Autosomal-Dominant-Polycystic-Kidney-Disease-ADPKD

RGLS4326 - Regulus Therapeutics

https://www.prnewswire.com/news-releases/regulus-therapeutics-completes-dosing-in-phase-1-multiple-ascending-dose-study-of-rgls4326-in-healthy-volunteers-for-the-treatment-of-autosomal-dominant-polycystic-kidney-disease-adpkd-301097728.html

Jul 22, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next